Raised $34M across disclosed rounds.[3][7]

Series A closed March 2025, led by Sequoia Capital.[3][4][7]

post-money valuation is not publicly disclosed.

Named investors include Sequoia Capital, Scale Venture Partners, Daniel Gross, Gokul Rajaram, Ted Zagat.[3][7]

Erez Druk, Co-Founder & CEO[3][6]

Andrey Bannikov, Co-Founder & CTO[3][6]

Valerie Zlotsky, Chief Marketing Officer[6]

Ziv Noy, VP of Finance & Operations[6]

Ted Obenchain, Head of Sales[6]

Gabrielle Wagner, Head of People[6]

Abridge · abridge.com · Same buyer (clinicians) and same workflow (AI scribe for clinical documentation), but Abridge targets large hospital systems while Freed targets small independent practices.[6]

Nabla · nabla.com · Same workflow (ambient AI scribe) and same buyer (clinicians), but Nabla focuses on enterprise health system deployments.[6]

Robin Healthcare · robinhealthcare.com · Same workflow (AI scribe for clinical notes) and same buyer (clinicians); Robin Healthcare is a known talent source for Freed.[6]

SmarterDx · smarterdx.com · Adjacent workflow (AI for clinical documentation and coding), but SmarterDx focuses on hospital revenue integrity rather than clinician workflow.[6]

The customer proof is company-sourced only. No independent source in this ledger confirms it.[8]

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.

Filled in the side panel for invited readers. This card carries sourced facts only.